Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Minnie Abromowitch, MD
Children's Hospital Medical Center, Cincinnati
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
176 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Prince of Wales Private Hospital
Randwick, New South Wales, Australia
- Royal Children'S Hospital
Herston, Brisbane, Queensland, Australia
- Women'S and Children'S Hospital
North Adelaide, South Australia, Australia
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Children'S & Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Janeway Children'S Health and Rehabilitation Centre
St. John's, Newfoundland and Labrador, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston General Hospital
Kingston, Ontario, Canada
- Children'S Hospital of Western Ontario
London, Ontario, Canada
- Children'S Hospital of Eastern Ontario
Ottawa, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital at Mcgill University Health Center
Montreal, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre at the University of Saskatchewan
Saskatoon, Saskatchewan, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Canada
- San Jorge Children'S Hospital
Santurce, Puerto Rico
- Swiss Pediatric Oncology Group Bern
Bern, Switzerland
- Swiss Pediatric Oncology Group Geneva
Geneva, Switzerland
- Swiss Pediatric Oncology Group Lausanne
Lausanne, Switzerland
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Jonathan Jaques Children'S Cancer Center at Miller Children'S Hospital
Long Beach, California, United States
- Childrens Hospital Los Angeles
Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Kaiser Permanente Medical Center - Oakland
Sacramento, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Children'S Hospital and Health Center - San Diego
San Diego, California, United States
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2000
- Primary completion
- 31 Aug 2008
- Completion
- 31 Mar 2015
- Last update posted
- 6 Aug 2019
- Registered enrollment
- 393
- Registry id
- NCT00004228
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.